Selected research
Industry Growth & Trends
Global Porcine Epidemic Diarrhea Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
The global Porcine Epidemic Diarrhea Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Porcine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Porcine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Porcine Epidemic Diarrhea Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Porcine Epidemic Diarrhea Vaccines include CAVAC, Zoetis, Qilu Animal Health, Nisseiken, Komipharm, Harrisvaccines and Green Cross Veterinary Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Porcine Epidemic Diarrhea Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Porcine Epidemic Diarrhea Vaccines market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Porcine Epidemic Diarrhea Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Porcine Epidemic Diarrhea Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Porcine Epidemic Diarrhea Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Porcine Epidemic Diarrhea Vaccines Market by Company
CAVAC
Zoetis
Qilu Animal Health
Nisseiken
Komipharm
Harrisvaccines
Green Cross Veterinary Products
Porcine Epidemic Diarrhea Vaccines Segment by Type
Live Vaccines
Killed Vaccines
Porcine Epidemic Diarrhea Vaccines Segment by Application
Piglets
Adults Pigs
Porcine Epidemic Diarrhea Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Epidemic Diarrhea Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Porcine Epidemic Diarrhea Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Epidemic Diarrhea Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Porcine Epidemic Diarrhea Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Porcine Epidemic Diarrhea Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Killed Vaccines
Applications
- Piglets
- Adults Pigs
Companies covered
- CAVAC
- Zoetis
- Qilu Animal Health
- Nisseiken
- Komipharm
- Harrisvaccines
- Green Cross Veterinary Products
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Porcine Epidemic Diarrhea Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.3 Porcine Epidemic Diarrhea Vaccines Market by Type
- 1.3.1 Live Vaccines
- 1.3.2 Killed Vaccines
- 1.4 Global Porcine Epidemic Diarrhea Vaccines Market Size by Type
- 1.4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Overview by Type (2021-2032)
- 1.4.2 Global Porcine Epidemic Diarrhea Vaccines Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Porcine Epidemic Diarrhea Vaccines Industry Trends
- 2.2 Porcine Epidemic Diarrhea Vaccines Industry Drivers
- 2.3 Porcine Epidemic Diarrhea Vaccines Industry Opportunities and Challenges
- 2.4 Porcine Epidemic Diarrhea Vaccines Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Porcine Epidemic Diarrhea Vaccines Revenue (2021-2026)
- 3.2 Global Top Players by Porcine Epidemic Diarrhea Vaccines Sales (2021-2026)
- 3.3 Global Top Players by Porcine Epidemic Diarrhea Vaccines Price (2021-2026)
- 3.4 Global Porcine Epidemic Diarrhea Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Porcine Epidemic Diarrhea Vaccines Major Company Production Sites & Headquarters
- 3.6 Global Porcine Epidemic Diarrhea Vaccines Company, Product Type & Application
- 3.7 Global Porcine Epidemic Diarrhea Vaccines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Porcine Epidemic Diarrhea Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Porcine Epidemic Diarrhea Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Porcine Epidemic Diarrhea Vaccines Tier 1, Tier 2, and Tier 3
4 Porcine Epidemic Diarrhea Vaccines Regional Status and Outlook
- 4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Porcine Epidemic Diarrhea Vaccines Historic Market Size by Region
- 4.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2021-2026)
- 4.2.2 Global Porcine Epidemic Diarrhea Vaccines Sales in Value by Region (2021-2026)
- 4.2.3 Global Porcine Epidemic Diarrhea Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Region
- 4.3.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2027-2032)
- 4.3.2 Global Porcine Epidemic Diarrhea Vaccines Sales in Value by Region (2027-2032)
- 4.3.3 Global Porcine Epidemic Diarrhea Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Porcine Epidemic Diarrhea Vaccines by Application
- 5.1 Porcine Epidemic Diarrhea Vaccines Market by Application
- 5.1.1 Piglets
- 5.1.2 Adults Pigs
- 5.2 Global Porcine Epidemic Diarrhea Vaccines Market Size by Application
- 5.2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Overview by Application (2021-2032)
- 5.2.2 Global Porcine Epidemic Diarrhea Vaccines Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 CAVAC
- 6.1.1 CAVAC Company Information
- 6.1.2 CAVAC Business Overview
- 6.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.1.5 CAVAC Recent Developments
- 6.2 Zoetis
- 6.2.1 Zoetis Company Information
- 6.2.2 Zoetis Business Overview
- 6.2.3 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Zoetis Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.2.5 Zoetis Recent Developments
- 6.3 Qilu Animal Health
- 6.3.1 Qilu Animal Health Company Information
- 6.3.2 Qilu Animal Health Business Overview
- 6.3.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.3.5 Qilu Animal Health Recent Developments
- 6.4 Nisseiken
- 6.4.1 Nisseiken Company Information
- 6.4.2 Nisseiken Business Overview
- 6.4.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.4.5 Nisseiken Recent Developments
- 6.5 Komipharm
- 6.5.1 Komipharm Company Information
- 6.5.2 Komipharm Business Overview
- 6.5.3 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Komipharm Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.5.5 Komipharm Recent Developments
- 6.6 Harrisvaccines
- 6.6.1 Harrisvaccines Company Information
- 6.6.2 Harrisvaccines Business Overview
- 6.6.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.6.5 Harrisvaccines Recent Developments
- 6.7 Green Cross Veterinary Products
- 6.7.1 Green Cross Veterinary Products Company Information
- 6.7.2 Green Cross Veterinary Products Business Overview
- 6.7.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product Portfolio
- 6.7.5 Green Cross Veterinary Products Recent Developments
7 North America by Country
- 7.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Country
- 7.1.1 North America Porcine Epidemic Diarrhea Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2021-2026)
- 7.1.3 North America Porcine Epidemic Diarrhea Vaccines Sales Forecast by Country (2027-2032)
- 7.2 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country
- 7.2.1 North America Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 7.2.3 North America Porcine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Country
- 8.1.1 Europe Porcine Epidemic Diarrhea Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2021-2026)
- 8.1.3 Europe Porcine Epidemic Diarrhea Vaccines Sales Forecast by Country (2027-2032)
- 8.2 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country
- 8.2.1 Europe Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 8.2.3 Europe Porcine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Country
- 9.1.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Country
- 9.2.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Porcine Epidemic Diarrhea Vaccines Sales by Country
- 10.1.1 South America Porcine Epidemic Diarrhea Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Porcine Epidemic Diarrhea Vaccines Sales by Country (2021-2026)
- 10.1.3 South America Porcine Epidemic Diarrhea Vaccines Sales Forecast by Country (2027-2032)
- 10.2 South America Porcine Epidemic Diarrhea Vaccines Market Size by Country
- 10.2.1 South America Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Porcine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 10.2.3 South America Porcine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country
- 11.1.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country
- 11.2.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Porcine Epidemic Diarrhea Vaccines Value Chain Analysis
- 12.1.1 Porcine Epidemic Diarrhea Vaccines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Porcine Epidemic Diarrhea Vaccines Production Mode & Process
- 12.2 Porcine Epidemic Diarrhea Vaccines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Porcine Epidemic Diarrhea Vaccines Distributors
- 12.2.3 Porcine Epidemic Diarrhea Vaccines Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst